Neurology

Resource Center

migraine

Research Summaries

FDA ALERT

FDA ALERT

FDA Approves Avlayah (Tividenofusp Alfa-Eknm) for Neurologic Manifestations of Hunter Syndrome in Pediatric Patients

03/26/2026

Ashton L. Stahl

The FDA has approved Avlayah (tividenofusp alfa-eknm) for certain pediatric patients with Hunter syndrome, marking the first approval targeting the disease's neurologic complications and offering clinicians...

03/26/2026

Research Summary

Research Summary

Ultrasound-Guided Nerve Blocks Show Comparable Efficacy in Chronic Resistant Migraine, Added Benefits in Select Patients

03/09/2026

Kate Young

The results from a recent randomized controlled trial showed that ultrasound-guided sphenopalatine ganglion (SPG) and greater occipital nerve blocks are equally effective in reducing headache frequency,...

03/09/2026

Research Summary

Research Summary

Fremanezumab Reduces Migraine Days in Children, Adolescents with Episodic Migraine

02/09/2026

Anthony Calabro, MA

A phase 3 randomized trial evaluated the efficacy and safety of fremanezumab for preventive treatment of episodic migraine in children and adolescents, addressing a significant evidence gap in pediatric...

02/09/2026

Research Summary

Research Summary

Safety of Combined Atogepant and Ubrogepant Use in US Adults with Episodic Migraine: TANDEM Study Results

01/21/2026

Ashton L. Stahl

A phase 4 TANDEM trial in the United States evaluated whether ubrogepant for acute migraine treatment can be safely added to atogepant and used daily for preventive therapy in adults with episodic migraine,...

01/21/2026

Research Summary

Research Summary

Study: Cognitive Frailty Affects Nearly 7% of Adults Over 50 With HIV

01/12/2026

Ashton L. Stahl

A large cross-sectional Italian study evaluated the prevalence of cognitive frailty and identified HIV-specific and clinical risk factors among adults 50 years or older living with HIV, highlighting the...

01/12/2026

April 2026

Current Issue

April 2026